Statistics for Nykode Therapeutics AS (id:10313 NYKD)

Valuation metrics

Market cap

727.54M

Enterprise value

6.26B

Trailing P/E (ttm)

-23.08

Forward P/E

-13.92

PEG ratio

-13.92

Price/Sales (ttm)

111.66

Price/Book (mrq)

4.78

Enterprise Value/Revenue

86.72

Enterprise Value/EBITDA

-9.72

Overview

Shares outstanding

326.55M

Float

192.89M

Shares short

% Held by insiders

0.46%

% Held by institutions

0.19%

Average volume (10 days)

5.27M

Average volume (90 days)

Price summary

52-Week low

1.55

52-Week high

21.40

52-Week change

-624.19%

Beta

1.31

50-Day moving average

4.83

200-Day moving average

11.84

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-2,018.32%

Operational effectiveness

Return on assets

-19.95%

Return on equity

-25.99%

Income statement

Revenue (ttm)

0.02

Revenue per share (ttm)

0.02

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-644,161,581.00

Net income to common (ttm)

-420,071,659.00

Diluted EPS (ttm)

-1.32

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.51B

Total cash per share (mrq)

0.42

Total debt (mrq)

53.03M

Total Debt/Equity (mrq)

3.15

Current ratio (mrq)

928.00%

Book value per share (mrq)

0.47

Cash flow

Cash flow statement

-967,965,203.00

Levered free cash flow (LFCF)

-457,735,739.00